Canandaigua National Bank & Trust Co. Purchases New Holdings in The Clorox Company $CLX

Canandaigua National Bank & Trust Co. acquired a new stake in shares of The Clorox Company (NYSE:CLXFree Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 12,031 shares of the company’s stock, valued at approximately $1,148,000.

A number of other hedge funds have also modified their holdings of CLX. Darwin Wealth Management LLC bought a new position in shares of Clorox in the second quarter worth about $29,000. Caitlin John LLC increased its holdings in shares of Clorox by 1,807.1% in the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares in the last quarter. Root Financial Partners LLC raised its position in Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after purchasing an additional 145 shares during the last quarter. Vision Financial Markets LLC lifted its holdings in Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after buying an additional 200 shares in the last quarter. Finally, Western Wealth Management LLC bought a new position in Clorox in the 1st quarter valued at $35,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Trading Up 1.2%

Shares of CLX stock opened at $105.97 on Thursday. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $128.90. The company has a market capitalization of $12.81 billion, a PE ratio of 21.98 and a beta of 0.54. The firm has a 50 day moving average price of $95.91 and a two-hundred day moving average price of $103.48. The company has a quick ratio of 0.65, a current ratio of 0.66 and a debt-to-equity ratio of 15.80.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.02. The company had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The firm’s quarterly revenue was down 2.0% compared to the same quarter last year. During the same quarter last year, the company earned $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, analysts predict that The Clorox Company will post 5.83 earnings per share for the current year.

Clorox Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be issued a dividend of $1.25 per share. This is a boost from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $5.00 annualized dividend and a dividend yield of 4.7%. Clorox’s payout ratio is presently 80.52%.

Wall Street Analyst Weigh In

Several analysts have weighed in on CLX shares. Wells Fargo & Company boosted their price objective on Clorox from $95.00 to $102.00 and gave the stock an “equal weight” rating in a report on Tuesday. Morgan Stanley reduced their price objective on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Barclays reaffirmed an “underweight” rating and set a $84.00 target price on shares of Clorox in a report on Tuesday. The Goldman Sachs Group reiterated a “sell” rating and set a $83.00 target price on shares of Clorox in a research report on Friday, May 1st. Finally, UBS Group lifted their price objective on Clorox from $100.00 to $105.00 and gave the stock a “neutral” rating in a research note on Tuesday. Twelve equities research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and an average price target of $102.40.

View Our Latest Stock Analysis on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.